Namodenoson Treatment of Advanced Pancreatic Cancer
Namodenoson Treatment of Advanced Pancreatic Cancer
Recruiting · NCT06387342 · Registry updated 2025-01-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Namodenoson Treatment of Advanced Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic neoplasm | Recruiting | Phase 2 | 2025-01-31 | NCT06387342 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Can-Fite BioPharma | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rabin Medical Center Institute of Oncology | Petah Tikva | Israel | 1 |